No abstract available
MeSH terms
-
Adenosine Monophosphate / analogs & derivatives
-
Adenosine Monophosphate / therapeutic use
-
Adult
-
Alanine / analogs & derivatives
-
Alanine / therapeutic use
-
Ampicillin / therapeutic use
-
Angioedema / immunology
-
Angioedema / physiopathology
-
Angioedema / therapy
-
Angioedema / virology*
-
Betacoronavirus / drug effects
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity
-
COVID-19
-
Coronavirus Infections / immunology
-
Coronavirus Infections / physiopathology
-
Coronavirus Infections / therapy
-
Coronavirus Infections / virology*
-
Diabetes Mellitus, Type 2 / immunology
-
Diabetes Mellitus, Type 2 / physiopathology
-
Diabetes Mellitus, Type 2 / therapy
-
Diabetes Mellitus, Type 2 / virology*
-
Female
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Hyperlipidemias / immunology
-
Hyperlipidemias / physiopathology
-
Hyperlipidemias / therapy
-
Hyperlipidemias / virology*
-
Intubation, Intratracheal
-
Obesity / immunology
-
Obesity / physiopathology
-
Obesity / therapy
-
Obesity / virology*
-
Pandemics
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / physiopathology
-
Pneumonia, Viral / therapy
-
Pneumonia, Viral / virology*
-
Respiration, Artificial
-
Respiratory Insufficiency / immunology
-
Respiratory Insufficiency / physiopathology
-
Respiratory Insufficiency / therapy
-
Respiratory Insufficiency / virology*
-
SARS-CoV-2
-
Treatment Outcome
Substances
-
remdesivir
-
Adenosine Monophosphate
-
Hydroxychloroquine
-
Ampicillin
-
Alanine